Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112533247 | 11253324 | 7 | F | 20140228 | 20160627 | 20150709 | 20160704 | PER | PHHY2014US097889 | NOVARTIS | 48.40 | YR | F | Y | 107.50000 | KG | 20160704 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112533247 | 11253324 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | UNK, QD | 22527 | CAPSULE | QD | ||||||||
| 112533247 | 11253324 | 2 | C | ZONEGRAN | ZONISAMIDE | 1 | Unknown | U | 0 | ||||||||||
| 112533247 | 11253324 | 3 | C | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 112533247 | 11253324 | 4 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112533247 | 11253324 | 1 | Multiple sclerosis |
| 112533247 | 11253324 | 2 | Migraine |
| 112533247 | 11253324 | 3 | Fatigue |
| 112533247 | 11253324 | 4 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112533247 | 11253324 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112533247 | 11253324 | Action tremor | |
| 112533247 | 11253324 | Arthralgia | |
| 112533247 | 11253324 | Blood calcium increased | |
| 112533247 | 11253324 | Blood cholesterol increased | |
| 112533247 | 11253324 | Blood triglycerides increased | |
| 112533247 | 11253324 | Cognitive disorder | |
| 112533247 | 11253324 | Concussion | |
| 112533247 | 11253324 | Condition aggravated | |
| 112533247 | 11253324 | Constipation | |
| 112533247 | 11253324 | Disturbance in attention | |
| 112533247 | 11253324 | Drug eruption | |
| 112533247 | 11253324 | Fall | |
| 112533247 | 11253324 | Gait disturbance | |
| 112533247 | 11253324 | Hirsutism | |
| 112533247 | 11253324 | Hyperlipidaemia | |
| 112533247 | 11253324 | Ingrowing nail | |
| 112533247 | 11253324 | Intervertebral disc displacement | |
| 112533247 | 11253324 | Laceration | |
| 112533247 | 11253324 | Ligament sprain | |
| 112533247 | 11253324 | Lymphocyte count decreased | |
| 112533247 | 11253324 | Micturition urgency | |
| 112533247 | 11253324 | Muscle strain | |
| 112533247 | 11253324 | Muscular weakness | |
| 112533247 | 11253324 | Suicidal ideation | |
| 112533247 | 11253324 | Temperature intolerance | |
| 112533247 | 11253324 | Type 2 diabetes mellitus | |
| 112533247 | 11253324 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112533247 | 11253324 | 2 | 20140410 | 0 | ||
| 112533247 | 11253324 | 3 | 20140521 | 20150512 | 0 | |
| 112533247 | 11253324 | 4 | 20140521 | 0 |